Dr. Christensen is recognized worldwide as an expert in learning technology. He has pioneered adaptive learning, data-driven content development, simulation and debriefing technologies. He is responsible for the strategy of Area9 Group’s businesses, that span from purpose-built platforms for optimization of business processes for large corporations over digital product design to corporate training based on intelligent, adaptive learning.
He founded his first company, Sophus Medical, in 1997 while still in medical school. Sophus Medical was acquired by Laerdal Medical in 2002. Dr. Christensen was responsible for Laerdal’s global learning technologies initiatives from 2002–2006. Dr. Christensen co-founded Area9 Group in 2006, which has been at the forefront of adaptive and personalized learning with more than 1500 adaptive learning products based on the Area9 technologies and millions of students using the systems every semester. Area9 Education was sold to McGraw-Hill Education in 2014 and Area9 Learning was established to focus on adaptive learning in corporate and organizational environments.
Dr. Christensen was part of the McGraw-Hill Higher Education leadership team from 2011 to 2014 and the MHE Executive Leadership Team from February 2014 to 2016, where he stepped down to focus on the rapidly growing Area9 Innovation and Area9 Learning enterprises.
He is currently the chairman of Altus Care (precision compliance software platform). He is also on several other boards. In 2017, Dr. Christensen was appointed entrepreneur in residence at the new translational accelerator at Brigham and Women’s Hospital-Harvard Medical School.
Precision medicine is much more than highly specific, new molecules.